A randomized trial of varenicline (Champix) for the treatment of cognitive and affective symptoms in Huntington's Disease

Trial Profile

A randomized trial of varenicline (Champix) for the treatment of cognitive and affective symptoms in Huntington's Disease

Recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Nov 2016

At a glance

  • Drugs Varenicline (Primary) ; Methylcellulose
  • Indications Huntington's disease
  • Focus Therapeutic Use
  • Acronyms VCAS-HD
  • Most Recent Events

    • 23 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top